TNNI3 and acute coronary syndrome: Given this uncertainty and the fact that hs-cTnI is the only troponin assay available in many settings, we aimed to evaluate the prognostic significance of hs-cTnI measured within the first 24 hours of hospitalization in ESKD patients on HD without clinical suspicion of acute coronary syndrome (ACS).